Advertisement

European Journal of Dermatology

, Volume 28, Issue 3, pp 415–417 | Cite as

Metastatic cutaneous apocrine carcinoma: a multidisciplinary approach incorporating endocrine therapy

  • Dai Ogata
  • Hideki Takeuchi
  • Yuki Shiomi
  • Eiichi Arai
  • Tetsuya Tsuchida
Correspondence

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ogata D, Kiyohara Y, Yoshikawa S, Kasami M. Treatment strategy for cutaneous apocrine carcinoma. Int J Clin Oncol 2014; 19: 712–5.CrossRefPubMedGoogle Scholar
  2. 2.
    Otsuka M, Yamasaki O, Kaji T, et al. Metastatic cutaneous apocrine adenocarcinoma treated with a combination of pertuzumab–based targeted therapy and taxane chemotherapy:a case report. JAMA Dermatol 2016; 152: 111–3.CrossRefPubMedGoogle Scholar
  3. 3.
    Fujisawa Y, Fujimoto M. Metastatic cutaneous apocrine carcinoma of the axilla successfully treated using systemic chemotherapy with i.v. epirubicin and cyclophosphamide followed by oral fluorinated pyrimidine. J Dermatol 2014; 41: 280–2.CrossRefPubMedGoogle Scholar
  4. 4.
    Hidaka T, Fujimura T, Watabe A, et al. Successful treatment of HER–2–positive metastatic apocrine carcinoma of the skin with lapatinib and capecitabine. Acta Derm Venereol 2012; 92: 654–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Piris A, Peng Y, Boussahmain C, et al. Cutaneous and mammary apocrine carcinomas have different immunoprofiles. Hum Pathol 2014; 45: 320–6.CrossRefPubMedGoogle Scholar

Copyright information

© John Libbey Eurotext 2018

Authors and Affiliations

  • Dai Ogata
    • 1
  • Hideki Takeuchi
    • 2
  • Yuki Shiomi
    • 1
  • Eiichi Arai
    • 3
  • Tetsuya Tsuchida
    • 1
  1. 1.Department of DermatologySaitama Medical UniversityMoroyama, SaitamaJapan
  2. 2.Department of Breast OncologySaitama Medical UniversityMoroyama, SaitamaJapan
  3. 3.Department of PathologySaitama Medical University International Medical CenterMoroyama, SaitamaJapan

Personalised recommendations